Underweight but metabolically abnormal phenotype: Metabolic features and its association with cardiovascular disease
Bixia Gao1, Luxia Zhang1, Minghui Zhao1
1Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.
Insights
Metabolically abnormal phenotypes are common in underweight Chinese adults and increase cardiovascular disease (CVD) risk. Preventive strategies for CVD should include underweight individuals with metabolic abnormalities.
Area of Science:
- Cardiology
- Metabolic Health
- Public Health
Background:
- Metabolic abnormalities are linked to cardiovascular disease (CVD) risk in normal and high body mass index (BMI) individuals.
- Limited research exists on metabolic features and CVD association, especially in underweight populations.
Purpose of the Study:
- To investigate the prevalence of metabolically abnormal phenotypes in underweight adults in China.
- To examine the association between underweight, metabolic status, and the presence of CVD and albuminuria.
Main Methods:
- Utilized a nationally representative sample of Chinese adults.
- Defined underweight as BMI <18.5kg/m(2).
- Classified participants as metabolically healthy (<2 metabolic syndrome criteria) or abnormal (≥2 criteria).
Main Results:
- 4.6% of 46,308 participants were underweight, with 16.4% of them being metabolically abnormal.
- Underweight, metabolically abnormal individuals showed higher odds of CVD (aOR 2.33) and albuminuria (aOR 2.56) compared to normal weight, metabolically healthy individuals.
- Leisure inactivity, mild occupational activity, and waist circumference were associated with metabolic abnormality in underweight participants.
Conclusions:
- Metabolically abnormal phenotypes are prevalent in the underweight Chinese population.
- Underweight individuals with metabolic abnormalities face an elevated risk of CVD.
- Preventive strategies for CVD should extend to metabolically abnormal underweight individuals.
Background:
Previous studies revealed that among people with normal and high body mass index (BMI), metabolic abnormalities contribute to the increased risk of cardiovascular disease (CVD). However, studies investigating the metabolic features and its association with CVD are limited.
Methods:
A national representative sample of adult population in China was used. Underweight was defined as BMI <18.5kg/m(2). Participants who had less than 2 criteria of metabolic syndrome were classified as metabolically healthy; those who had 2 or more criteria of metabolic syndrome were classified as metabolically abnormal. Presence of CVD and albuminuria were compared among groups stratified by BMI and metabolic status.
Results:
Among 46308 participants, 2267 (4.6%) were classified as underweight; and 372 (16.4%) of them were identified as metabolically abnormal. Metabolic features were comparable between underweight but metabolically abnormal participants and obese participants. Compared with participants with normal weight and normal metabolic features, the underweight but metabolically abnormal participants were more likely to have CVD and albuminuria, with an adjusted odds ratio of 2.33 (95% confidence interval (CI) 1.34-4.05) and 2.56 (95% CI 1.86-3.52), respectively. Among underweight participants, factors associated with metabolic abnormal phenotype included leisure time physical inactivity, mild occupational physical activity, and waist circumference.
Conclusions:
Metabolically abnormal phenotype is not rare among underweight population in China, and preventive strategy against CVD should also be considered in that population.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Coronary Artery Disease II: Pathophysiology
Obesity
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cholesterol: Significance and Regulation
Considering cholesterol and...


